ES2052712T3 - Vector de levadura. - Google Patents

Vector de levadura.

Info

Publication number
ES2052712T3
ES2052712T3 ES88303157T ES88303157T ES2052712T3 ES 2052712 T3 ES2052712 T3 ES 2052712T3 ES 88303157 T ES88303157 T ES 88303157T ES 88303157 T ES88303157 T ES 88303157T ES 2052712 T3 ES2052712 T3 ES 2052712T3
Authority
ES
Spain
Prior art keywords
dna sequence
yeast
place
micron
yeast vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88303157T
Other languages
English (en)
Inventor
Edward Hinchliffe
Simon Andrew Chinery
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Albumedix Ltd
Original Assignee
Delta Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878708495A external-priority patent/GB8708495D0/en
Priority claimed from GB878718347A external-priority patent/GB8718347D0/en
Application filed by Delta Biotechnology Ltd filed Critical Delta Biotechnology Ltd
Application granted granted Critical
Publication of ES2052712T3 publication Critical patent/ES2052712T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

UN VECTOR PLAMSIDO DE 2 MICRAS PARA TRANSFORMAR LEVADURA, ESPECIALMENTE LEVADURA DE CERVEZA. COMPRENDE UNA SECUENCIA DE ADN QUE PERMITE LA PROPAGACION DEL PLASMIDO EN BACTERIAS, DOS COPIAS DE LUGAR DE RECOMBINACION FLP DE 74 PARES DE BASES DEL PLASMIDO DE 2 MICRAS EN ORIENTACION DIRECTA Y UNA SECUENCIA DE ADN QUE CODIFICA PARA UNA PROTEINA O UN PEPTIDO DE INTERES. ELPLASMIDO ESTA CONSTRUIDO DE TAL MANERA QUE EN LA LEVADURA LA SECUENCIA DE ADN BACTERIANA SE PIERDE ESPONTANEAMENTE. ES ACONSEJABLE INTRODUCIR EN EL LUGAR DE SNABI UN "GEN DE INTERES".
ES88303157T 1987-04-09 1988-04-08 Vector de levadura. Expired - Lifetime ES2052712T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878708495A GB8708495D0 (en) 1987-04-09 1987-04-09 Yeast-disintegration vector
GB878718347A GB8718347D0 (en) 1987-08-03 1987-08-03 Yeast-disintegration vector

Publications (1)

Publication Number Publication Date
ES2052712T3 true ES2052712T3 (es) 1994-07-16

Family

ID=26292122

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88303157T Expired - Lifetime ES2052712T3 (es) 1987-04-09 1988-04-08 Vector de levadura.

Country Status (13)

Country Link
US (1) US5637504A (es)
EP (1) EP0286424B1 (es)
JP (1) JP2873012B2 (es)
AU (1) AU613030B2 (es)
BR (1) BR8806573A (es)
CA (1) CA1339099C (es)
DE (1) DE3888381T2 (es)
ES (1) ES2052712T3 (es)
FI (1) FI95285C (es)
GB (1) GB2210621B (es)
HU (1) HU213344B (es)
IE (1) IE63424B1 (es)
WO (1) WO1988008027A1 (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8615701D0 (en) * 1986-06-27 1986-08-06 Delta Biotechnology Ltd Stable gene integration vector
SG84484A1 (en) * 1991-02-25 2001-11-20 Ciba Geigy Ag Improved yeast vectors
GB9107628D0 (en) 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
US5993805A (en) 1991-04-10 1999-11-30 Quadrant Healthcare (Uk) Limited Spray-dried microparticles and their use as therapeutic vehicles
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
EP1009836A1 (en) * 1997-09-05 2000-06-21 Pentapharm A.G. Expression vector for improved production of polypeptides in yeast
US6358705B1 (en) 1998-07-16 2002-03-19 Novo Nordisk A/S Method of making proteins in transformed yeast cells
FR2784394B1 (fr) * 1998-10-09 2001-01-05 Lesaffre & Cie Cassette d'integration-excision
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
US20050100991A1 (en) * 2001-04-12 2005-05-12 Human Genome Sciences, Inc. Albumin fusion proteins
US6926898B2 (en) * 2000-04-12 2005-08-09 Human Genome Sciences, Inc. Albumin fusion proteins
US6645767B1 (en) * 2000-10-03 2003-11-11 Carnegie Mellon University Cells engineered to contain genes of interest without expressed bacterial sequences and materials and methods therefor
US7507413B2 (en) * 2001-04-12 2009-03-24 Human Genome Sciences, Inc. Albumin fusion proteins
US20050054051A1 (en) * 2001-04-12 2005-03-10 Human Genome Sciences, Inc. Albumin fusion proteins
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
CA2841097A1 (en) 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Albumin and g-csf fusion proteins
WO2005003296A2 (en) 2003-01-22 2005-01-13 Human Genome Sciences, Inc. Albumin fusion proteins
WO2003059934A2 (en) * 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Albumin fusion proteins
US20050222023A1 (en) * 2002-02-07 2005-10-06 Hans-Peter Hauser Albumin-fused kunitz domain peptides
US20060122374A1 (en) 2002-02-07 2006-06-08 Peter Mertins Albumin-fused anti-angiogenesis peptides
GB0217033D0 (en) 2002-07-23 2002-08-28 Delta Biotechnology Ltd Gene and polypeptide sequences
CN1938333A (zh) * 2003-12-03 2007-03-28 达尔塔生物技术有限公司 白介素－11融合蛋白
GB0329681D0 (en) * 2003-12-23 2004-01-28 Delta Biotechnology Ltd Gene expression technique
GB0329722D0 (en) * 2003-12-23 2004-01-28 Delta Biotechnology Ltd Modified plasmid and use thereof
US9057061B2 (en) 2003-12-23 2015-06-16 Novozymes Biopharma Dk A/S Gene expression technique
CN102816241B (zh) * 2004-02-09 2015-07-22 人类基因科学公司 清蛋白融合蛋白
EP2330200B1 (en) 2004-12-23 2017-04-05 Albumedix A/S Gene expression technique
DK2046826T3 (da) 2006-07-24 2011-10-24 Biorexis Pharmaceutical Corp Exendin-fusionsproteiner
EP2594583A1 (en) 2007-08-08 2013-05-22 Novozymes Biopharma DK A/S Transferrin variants and conugates
BRPI1004940A2 (pt) 2009-01-16 2018-06-19 Teva Pharma composição farmacêutica
US20110294988A1 (en) 2009-02-06 2011-12-01 Novozymes Bio Pharma DK A/S Purification Process
SG172789A1 (en) 2009-02-11 2011-08-29 Novozymes Biopharma Dk As Albumin variants and conjugates
AU2010311332B2 (en) 2009-10-30 2015-04-23 Albumedix Ltd. Albumin variants
KR20130070576A (ko) 2010-04-09 2013-06-27 노보자임스 바이오파마 디케이 에이/에스 알부민 유도체 및 변이체
WO2012150319A1 (en) 2011-05-05 2012-11-08 Novozymes Biopharma Dk A/S Albumin variants
HU231053B1 (hu) * 2011-09-08 2020-03-30 Szegedi Tudományegyetem Rézrezisztens, fengicin hipertermelő Bacillus mojavensis törzs növényi kórokozók elleni védekezésre, alkalmazása és az ezt tartalmazó készítmények
HK1200842A1 (en) 2011-11-18 2015-08-14 Albumedix Ltd Proteins with improved half-life and other properties
EP3330283A3 (en) 2012-03-16 2018-07-11 Albumedix A/S Albumin variants
CA2890766A1 (en) 2012-11-08 2014-05-15 Novozymes Biopharma Dk A/S Albumin variants
US20140271538A1 (en) 2013-03-15 2014-09-18 Teva Pharmaceutical Industries Ltd. Recombinant Human Albumin-Human Granulocyte Colony Stimulating Factor for the Prevention of Neutropenia in Pediatric Patients
BR112018003179A2 (pt) 2015-08-20 2018-09-25 Albumedix As conjugados e variantes de albumina
JP2018093806A (ja) * 2016-12-14 2018-06-21 国立大学法人山口大学 酵母でタンパク質を過剰発現させる方法
CN112852860B (zh) * 2021-02-04 2023-04-28 天津大学 质粒载体及其在构建多拷贝表达系统中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588684A (en) * 1983-04-26 1986-05-13 Chiron Corporation a-Factor and its processing signals
GB8334261D0 (en) * 1983-12-22 1984-02-01 Bass Plc Fermentation processes
GB8510219D0 (en) * 1985-04-22 1985-05-30 Bass Plc Isolation of fermentation products
IL80510A0 (en) * 1985-11-08 1987-02-27 Genetics Inst Improved yeast strains
GB8615701D0 (en) * 1986-06-27 1986-08-06 Delta Biotechnology Ltd Stable gene integration vector
AU8171087A (en) * 1986-10-27 1988-05-25 Whitehead Institute For Biomedical Research Gene amplification using retrotransposons
ES2052062T3 (es) * 1988-06-11 1994-07-01 Ciba Geigy Ag Nuevos polipeptidos con actividad anticoagulante.

Also Published As

Publication number Publication date
DE3888381T2 (de) 1994-07-28
HU213344B (en) 1997-05-28
DE3888381D1 (de) 1994-04-21
FI885705L (fi) 1988-12-08
HUT52560A (en) 1990-07-28
CA1339099C (en) 1997-07-29
FI95285B (fi) 1995-09-29
GB2210621A (en) 1989-06-14
JPH01503275A (ja) 1989-11-09
JP2873012B2 (ja) 1999-03-24
AU613030B2 (en) 1991-07-25
AU1540388A (en) 1988-11-04
EP0286424B1 (en) 1994-03-16
IE881046L (en) 1988-10-09
WO1988008027A1 (en) 1988-10-20
FI95285C (fi) 1996-01-10
IE63424B1 (en) 1995-04-19
GB8828753D0 (en) 1989-02-01
GB2210621B (en) 1990-11-21
US5637504A (en) 1997-06-10
EP0286424A1 (en) 1988-10-12
BR8806573A (pt) 1989-10-31
FI885705A0 (fi) 1988-12-08

Similar Documents

Publication Publication Date Title
EP0585257A4 (en) DNA AND AMINO ACID SEQUENCE SPECIFIC TO NATURAL K KILLER CELLS.
ES2056817T3 (es) Transformacion de trichoderma.
ES2182837T3 (es) Piran-2-onas y 5,6-dihidropiran-2-onas utiles en el tratamiento del sida y de otros retrovirus.
ES2064077T3 (es) Integracion estable de adn en genomas bacterianos.
CA2185712A1 (en) Enhanced virus-mediated dna transfer
DK1012259T3 (da) Tumorrettet vektor
NO882873L (no) Ikke-gulnende beleggspreparater og deres anvendelse.
ATE63748T1 (de) Enzymwiderstandsfaehige immunomodulatorische peptide.
IT1208603B (it) Procedimento per indurre protoginia in piante di zea mays e relativo zea mays protogino.
MX9202815A (es) Codificacion del polideoxirribonucleotido, plasmida y procedimiento para preparar un clono que contiene plasmida.
ATE177757T1 (de) Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17
BR9407278A (pt) Formulações farmacêuticas do fator de crescimento dos nervos
EP0873049A4 (es)
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
ATE61937T1 (de) Antigenische zubereitungen und isolierung von solchen zubereitungen.
ES2055686T3 (es) Procedimiento para preparar proteinas con factor de granulocitos-macrofagos "estimulador de colonias".
ES2174835T3 (es) Carboxilasa dependiente de la vitamina k.
ES2146214T3 (es) Vacunas para actinobacillus pleuropneumoniae.
AR002742A1 (es) Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn
IL87391A0 (en) Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them
RU94046362A (ru) Последовательности днк, плазмиды, применение плазмиды, растения, бактерии, применение последовательности днк, дрожжевые штаммы
NZ230654A (en) Anti-cell proliferative penta and hexa peptides
AU580157B2 (en) Pantethine component for hair permanent waving
ES2080486T3 (es) Sg(beta)-1,4-galactanasa y una secuencia de adn.
ES8504248A1 (es) Procedimiento para la fabricacion de un plasmido recombinante que contiene un aminoacido

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 286424

Country of ref document: ES